Neonatal Hormone Concentrations and Risk of Testicular Germ Cell Tumors (TGCT).

MLA

Morimoto, Libby M., et al. “Neonatal Hormone Concentrations and Risk of Testicular Germ Cell Tumors (TGCT).” Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, vol. 27, no. 4, Apr. 2018, pp. 488–95. EBSCOhost, https://doi.org/10.1158/1055-9965.EPI-17-0879.

APA

Morimoto, L. M., Zava, D., McGlynn, K. A., Stanczyk, F. Z., Kang, A. Y., Ma, X., Wiemels, J. L., & Metayer, C. (2018). Neonatal Hormone Concentrations and Risk of Testicular Germ Cell Tumors (TGCT). Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 27(4), 488–495. https://doi.org/10.1158/1055-9965.EPI-17-0879

Chicago

Morimoto, Libby M, David Zava, Katherine A McGlynn, Frank Z Stanczyk, Alice Y Kang, Xiaomei Ma, Joseph L Wiemels, and Catherine Metayer. 2018. “Neonatal Hormone Concentrations and Risk of Testicular Germ Cell Tumors (TGCT).” Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 27 (4): 488–95. doi:10.1158/1055-9965.EPI-17-0879.